Bristol-Myers Squibb Unusual Options Activity For October 06
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Bristol-Myers Squibb (NYSE:BMY), with 70% of recent trades being bearish. The price target for the company, based on volume and open interest, is between $52.5 and $62.5. The current price of BMY is $56.2, down 0.39%. Analysts from TD Cowen, Truist Securities, and Cantor Fitzgerald have given price targets of $66, $84, and $75 respectively.
October 06, 2023 | 3:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bristol-Myers Squibb has seen a bearish stance from a significant investor, with a price target between $52.5 and $62.5. The current price is $56.2, down 0.39%.
The bearish stance from a significant investor, along with the current downward trend in price, suggests a negative short-term impact on Bristol-Myers Squibb's stock. The price targets given by analysts are higher than the current price, which could indicate potential for growth in the longer term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100